Valuation UCB London S.E.

Stocks

Market Closed - London S.E. 11:30:00 2026-09-14 EDT			5-day change	1st Jan Change
209.95 ^EUR	+1.74%		-1.26%	-11.33%

09-11	AlphaValue/Baader Europe Sees UCB Share Drop as 'Rare Window of Affordability'; Price Target Up	MT
09-10	UCB: A rare window of affordability

Data adjusted to current consolidation scope

Fiscal Period: December	2021	2022	2023	2024	2025	2026	2027	2028
Market Cap ¹	18,947	13,973	14,969	36,464	45,333	40,134	-	-
Change	-	-26.25%	7.12%	143.6%	24.32%	-11.47%	-	-
Enterprise Value (EV) ¹	19,807	15,973	17,146	37,918	45,326	40,440	38,327	35,767
Change	-	-19.36%	7.34%	121.15%	19.54%	-10.78%	-5.23%	-6.68%
P/E	17.9x	33.4x	44.8x	34.3x	29.1x	21x	17.4x	14.3x
PBR	2.32x	1.58x	1.67x	3.64x	4.18x	3.33x	2.91x	2.4x
PEG	-	-0.6x	-2.2x	0x	0.6x	1x	0.8x	0.7x
Capitalization / Revenue	3.28x	2.53x	2.85x	5.93x	5.86x	4.62x	4.15x	3.73x
EV / Revenue	3.43x	2.9x	3.26x	6.16x	5.86x	4.65x	3.96x	3.33x
EV / EBITDA	12.1x	12.7x	12.7x	25.7x	17.2x	13.3x	10.5x	8.38x
EV / EBIT	15x	23.7x	26.1x	45.4x	22.6x	16.5x	12.8x	9.79x
EV / FCF	15.6x	18.4x	38.5x	41.2x	24.6x	21.2x	14.5x	11.5x
FCF Yield	6.42%	5.43%	2.6%	2.43%	4.06%	4.72%	6.9%	8.72%
Dividend per Share ²	1.3	1.33	1.36	1.39	1.45	1.457	1.502	1.534
Rate of return	1.3%	1.81%	1.72%	0.72%	0.61%	0.69%	0.71%	0.73%
EPS ²	5.6	2.2	1.76	5.61	8.2	10.01	12.13	14.74
Distribution rate	23.2%	60.5%	77.3%	24.8%	17.7%	14.5%	12.4%	10.4%
Net sales ¹	5,777	5,517	5,252	6,152	7,741	8,695	9,677	10,751
EBITDA ¹	1,641	1,260	1,349	1,476	2,636	3,052	3,644	4,267
EBIT ¹	1,318	675	657	836	2,009	2,458	2,997	3,652
Net income ¹	1,058	418	343	1,065	1,558	1,931	2,325	2,816
Net Debt ¹	860	2,000	2,177	1,454	-7	305.5	-1,808	-4,367
Reference price ²	100.35	73.56	78.90	192.20	238.60	210.50	210.50	210.50
Nbr of stocks (in thousands)	188,812	189,959	189,721	189,720	189,996	190,663	-	-
Announcement Date	2/24/22	2/22/23	2/28/24	2/27/25	2/24/26	-	-	-

¹EUR in Million²EUR

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
REGENERON PHARMACEUTICALS, INC.	18.1x	4.19x	9.84x	0.5%	79.26B
MODERNA, INC.	-17.17x	25.62x	-16.63x	-.--%	58.56B
CSL LIMITED	19.65x	4.21x	13.08x	2.5%	58.62B
SAMSUNG BIOLOGICS CO.,LTD.	34.47x	11.73x	22.49x	-.--%	48.75B
UCB	20.54x	4.54x	12.95x	0.71%	46.32B
BIOGEN INC.	37.49x	3.54x	13.51x	-.--%	32.12B
INCYTE CORPORATION	54.21x	3.43x	26.59x	-.--%	24.77B
INNOVENT BIOLOGICS, INC.	62.21x	6.52x	39.5x	-.--%	21.5B
SWEDISH ORPHAN BIOVITRUM AB	22.98x	4.94x	12.86x	-.--%	15.97B
Average	28.05x	7.64x	14.91x	0.41%	42.87B
Weighted average by Cap.	21.93x	8.50x	11.44x	0.57%